As of last week, the American Red Cross began allowing homosexual men who engage in risky anal sex to donate blood after a 90-day waiting period. The previous deferral period was 12 months.
Thanks to newly implemented guidance by the Food and Drug Administration, gay men who practice sodomy are permitted to give blood so long as they haven’t taken any new sex partners within the preceding three months. This policy, first issued in 2020 during the Covid “public health emergency,” is now in effect permanently.
While the American Red Cross does not collect blood in Alaska, the Blood Bank of Alaska collects more than 20,000 units of blood annually from an estimated 24,000 Alaskan blood donations. In a statement about the FDA changes, the groups said it “follows all FDA mandates and guidelines.”
The FDA recommendations come despite widespread knowledge that those who engage in homosexual “sex” have much higher rates of HIV and other sexual diseases compared to the general population.
According to the CDC’s own data, homosexual men comprise a full 70% of all new HIV cases, while comprising a tiny fraction of the general population.
With the new policy, blood collection groups are told to ask every blood donor – regardless of sex – whether they have engaged in sex with multiple partners over the previous 90 days. Those who have, are then asked whether they’ve engaged in anal sex. If they have, they cannot give blood.
ALASKA WATCHMAN DIRECT TO YOUR INBOX
Anal sex, which is widely associated with sexual disease, is a common practice in one out of three homosexual men, according to the National Center for Biotechnology Information.
The safety of the new recommendations is unclear, even according to the FDA. The federal agency’s statement expresses concern about inaccurate blood screenings and potential false negatives, which could result in tainted blood donations.
“Although undetectable equals untransmissible for sexual transmission, this does not apply to transfusion transmission,” the FDA said in May.
The FDA also admitted the previous policy was effective, stating that longer deferral times and other precautions “progressively reduced the risk of HIV transmission from blood transfusion over time, from about 1 in 2,500 units prior to HIV testing in the 1980’s to an estimated residual risk of about 1 in 1.47 million transfusions in 2022.”